MAGELLAN HEALTH INC: 10-Q filed 2010-10-29
What MAGELLAN HEALTH INC reported in its quarterly report filed 2010-10-29 (fiscal Q3 2010): 32 published measures, 86 facts as tagged in accession 0001047469-10-009001.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2010-10-29
- Fiscal period
- fiscal Q3 2010
- Accession
- 0001047469-10-009001 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All MAGELLAN HEALTH INC filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2010-09-30 | 1,490,917,000 | USD | |
| At 2009-12-31 | 1,441,041,000 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2010-09-30 | 475,739,000 | USD | |
| At 2009-12-31 | 490,549,000 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2010-09-30 | 284,639,000 | USD | |
| At 2009-12-31 | 196,507,000 | USD | |
| At 2009-09-30 | 142,205,000 | USD | |
| At 2008-12-31 | 211,825,000 | USD |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-01-01 to 2010-09-30 | 254,279,000 | USD | 273 |
| 2009-01-01 to 2009-09-30 | 100,623,000 | USD | 273 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-01-01 to 2010-09-30 | 32,201,000 | USD | 273 |
| 2009-01-01 to 2009-09-30 | 25,808,000 | USD | 273 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-07-01 to 2010-09-30 | 750,319,000 | USD | 92 |
| 2010-01-01 to 2010-09-30 | 2,220,030,000 | USD | 273 |
| 2009-07-01 to 2009-09-30 | 667,589,000 | USD | 92 |
| 2009-01-01 to 2009-09-30 | 1,922,905,000 | USD | 273 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-01-01 to 2010-09-30 | -53,505,000 | USD | 273 |
| 2009-01-01 to 2009-09-30 | -63,251,000 | USD | 273 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-01-01 to 2010-09-30 | -112,642,000 | USD | 273 |
| 2009-01-01 to 2009-09-30 | -106,992,000 | USD | 273 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2010-09-30 | 661,654,000 | USD | |
| At 2009-12-31 | 555,923,000 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-07-01 to 2010-09-30 | 33,450,000 | shares | 92 |
| 2010-01-01 to 2010-09-30 | 33,715,000 | shares | 273 |
| 2009-07-01 to 2009-09-30 | 35,128,000 | shares | 92 |
| 2009-01-01 to 2009-09-30 | 35,426,000 | shares | 273 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-07-01 to 2010-09-30 | 34,171,000 | shares | 92 |
| 2010-01-01 to 2010-09-30 | 34,345,000 | shares | 273 |
| 2009-07-01 to 2009-09-30 | 35,331,000 | shares | 92 |
| 2009-01-01 to 2009-09-30 | 35,566,000 | shares | 273 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-07-01 to 2010-09-30 | 1.34 | USD/shares | 92 |
| 2010-01-01 to 2010-09-30 | 3.14 | USD/shares | 273 |
| 2009-07-01 to 2009-09-30 | 0.88 | USD/shares | 92 |
| 2009-01-01 to 2009-09-30 | 1.78 | USD/shares | 273 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-07-01 to 2010-09-30 | 1.31 | USD/shares | 92 |
| 2010-01-01 to 2010-09-30 | 3.08 | USD/shares | 273 |
| 2009-07-01 to 2009-09-30 | 0.88 | USD/shares | 92 |
| 2009-01-01 to 2009-09-30 | 1.77 | USD/shares | 273 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-07-01 to 2010-09-30 | 28,137,000 | USD | 92 |
| 2010-01-01 to 2010-09-30 | 71,500,000 | USD | 273 |
| 2009-07-01 to 2009-09-30 | 17,833,000 | USD | 92 |
| 2009-01-01 to 2009-09-30 | 40,470,000 | USD | 273 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2010-09-30 | 108,247,000 | USD | |
| At 2009-12-31 | 108,219,000 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-07-01 to 2010-09-30 | 3,596,000 | USD | 92 |
| 2010-01-01 to 2010-09-30 | 11,830,000 | USD | 273 |
| 2009-07-01 to 2009-09-30 | 4,124,000 | USD | 92 |
| 2009-01-01 to 2009-09-30 | 16,724,000 | USD | 273 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2010-09-30 | 805,872,000 | USD | |
| At 2009-12-31 | 753,588,000 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-07-01 to 2010-09-30 | 482,000 | USD | 92 |
| 2010-01-01 to 2010-09-30 | 1,751,000 | USD | 273 |
| 2009-07-01 to 2009-09-30 | 650,000 | USD | 92 |
| 2009-01-01 to 2009-09-30 | 1,734,000 | USD | 273 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2010-09-30 | 352,730,000 | USD | |
| At 2009-12-31 | 369,164,000 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2010-09-30 | 22,702,000 | USD | |
| At 2009-12-31 | 27,086,000 | USD |
Goodwill carrying amount
Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2010-09-30 | 426,939,000 | USD | |
| At 2009-12-31 | 426,471,000 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2010-09-30 | 99,916,000 | USD | |
| At 2009-12-31 | 114,434,000 | USD |
Common-stock repurchase payments
Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-01-01 to 2010-09-30 | 74,427,000 | USD | 273 |
| 2009-01-01 to 2009-09-30 | 67,070,000 | USD | 273 |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2010-09-30 | 647,848,000 | USD | |
| At 2009-12-31 | 614,483,000 | USD |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2010-09-30 | 135,000 | USD | |
| At 2009-12-31 | 114,000 | USD |
Total equity including noncontrolling interests
Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2010-09-30 | 1,015,178,000 | USD | |
| At 2009-12-31 | 950,492,000 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2010-09-30 | 56,700,000 | USD | |
| At 2009-12-31 | 64,812,000 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2010-09-30 | 2,402,000 | USD | |
| At 2009-12-31 | 2,703,000 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2010-09-30 | 95,262,000 | USD | |
| At 2009-12-31 | 93,760,000 | USD |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-07-01 to 2010-09-30 | 44,784,000 | USD | 92 |
| 2010-01-01 to 2010-09-30 | 105,731,000 | USD | 273 |
| 2009-07-01 to 2009-09-30 | 30,987,000 | USD | 92 |
| 2009-01-01 to 2009-09-30 | 62,946,000 | USD | 273 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-07-01 to 2010-09-30 | 13,950,000 | USD | 92 |
| 2010-01-01 to 2010-09-30 | 41,607,000 | USD | 273 |
| 2009-07-01 to 2009-09-30 | 12,154,000 | USD | 92 |
| 2009-01-01 to 2009-09-30 | 33,713,000 | USD | 273 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-01-01 to 2010-09-30 | -10,279,000 | USD | 273 |
| 2009-01-01 to 2009-09-30 | 7,139,000 | USD | 273 |
Inspect the source
- Entity
- MAGELLAN HEALTH INC / CIK 0000019411
- Captured
- SEC response SHA-256
51abf13b428b7bf61a9743ee14a8ed424ab34b20dccd53e1c906533cd9ec8c4e
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000019411.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))